Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bromoouridine
2. Radibud
3. Brudr
4. 5-budr
5. Mls002702842
6. Chembl277625
7. 5-bromo-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
8. Nsc 38297
9. 5-bromo-1-(2-deoxypentofuranosyl)pyrimidine-2,4(1h,3h)-dione
10. Bromodeoxyuridine (brdu)
11. (+)-5-bromo-2'-deoxyuridine
12. Mfcd00006529
13. Bdu
14. 2'-deoxy-5-bromouridine
15. 5-bromo-2?-deoxyuridine
16. Schembl27756
17. Cid_236184
18. Wovkysahuynsmh-uhfffaoysa-
19. Dtxsid00859035
20. 5-bromo-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione
21. Nsc38297
22. Bbl100003
23. Bdbm50016787
24. Stl510779
25. Ls-13619
26. Nci60_003667
27. Smr001550589
28. Sy019490
29. Db-053327
30. Wln: T6nvmvj Ee A- Et5otj B1q Cq
31. Ft-0620085
32. 5-bromo-2 Inverted Exclamation Mark -deoxyuridine
33. 5-bromo-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione
34. Broxuridine, Broxuridine (5-bromouracil Deoxyriboside, 5-bromo-2'-deoxyuridine)
35. 5-bromo-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione (c-5-bromo-2-deoxyuridine)
36. 5-bromo-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione(brdurd)
37. 5-bromo-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione(bromodeoxyuridine)
| Molecular Weight | 307.10 g/mol |
|---|---|
| Molecular Formula | C9H11BrN2O5 |
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 305.98513 g/mol |
| Monoisotopic Mass | 305.98513 g/mol |
| Topological Polar Surface Area | 99.1 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 386 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Mls002702842 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mls002702842, including repackagers and relabelers. The FDA regulates Mls002702842 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mls002702842 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mls002702842 supplier is an individual or a company that provides Mls002702842 active pharmaceutical ingredient (API) or Mls002702842 finished formulations upon request. The Mls002702842 suppliers may include Mls002702842 API manufacturers, exporters, distributors and traders.
click here to find a list of Mls002702842 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mls002702842 DMF (Drug Master File) is a document detailing the whole manufacturing process of Mls002702842 active pharmaceutical ingredient (API) in detail. Different forms of Mls002702842 DMFs exist exist since differing nations have different regulations, such as Mls002702842 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mls002702842 DMF submitted to regulatory agencies in the US is known as a USDMF. Mls002702842 USDMF includes data on Mls002702842's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mls002702842 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mls002702842 suppliers with USDMF on PharmaCompass.
Mls002702842 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mls002702842 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mls002702842 GMP manufacturer or Mls002702842 GMP API supplier for your needs.
A Mls002702842 CoA (Certificate of Analysis) is a formal document that attests to Mls002702842's compliance with Mls002702842 specifications and serves as a tool for batch-level quality control.
Mls002702842 CoA mostly includes findings from lab analyses of a specific batch. For each Mls002702842 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mls002702842 may be tested according to a variety of international standards, such as European Pharmacopoeia (Mls002702842 EP), Mls002702842 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mls002702842 USP).
LOOKING FOR A SUPPLIER?
